Use of GLP-1 receptor agonists was associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes. Glucagon-like peptide-1 (GLP-1) receptor ...

The data also showed that low dose MC4R agonist bremelanotide stopped the rapid weight regain seen after ending GLP-1/GIP tirzepatide treatment." Topline data results from the study were highly ...

underscoring the potential of MC4R agonists as a valuable therapy for long-term weight maintenance.

Institute of Reproductive Medicine, School of Medicine, Nantong University, Nantong 226000, China ...

New research into the use of beta agonists released this week raises concerns about the animal health and welfare of feedlot cattle. The peer-reviewed article, while acknowledging “significant ...

Inflammation in preschool cystic fibrosis is of mixed phenotype, extends beyond the lung and is differentially modified by CFTR modulators ...

iOS 18.5 Developer Beta 3 fixes a black screen issue in Vision Pro app The Mail app gets a quick shortcut for toggling Contact Photos Apple also released iOS 18.5 Public Beta 2 update for iPhone ...

Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United ...

"One of the important research questions that the study was designed to answer was whether a low- dose of an MC4R agonist could support long-term weight loss maintenance. We're excited with the ...

The researchers found that while most glucose-lowering therapies were not significantly associated with a reduction in dementia risk, one class of drugs—known as GLP-1 receptor agonists (GLP ...